BRISTOL MYERS SQUIBB FDA Approval NDA 019915

NDA 019915

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #019915

Documents

Letter2003-06-08
Letter2009-02-13
Letter2002-08-29
Letter2003-11-05
Other Important Information from FDA2006-06-09
Label2003-06-08
Review2003-07-08
Pediatric Medical Review1900-01-01
Pediatric Written Request1900-01-01
Pediatric Amendment 11900-01-01
Pediatric Statistical Review1900-01-01

Application Sponsors

NDA 019915BRISTOL MYERS SQUIBB

Marketing Status

Discontinued002
Discontinued003
Discontinued004

Application Products

002TABLET;ORAL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MONOPRILFOSINOPRIL SODIUM
003TABLET;ORAL20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MONOPRILFOSINOPRIL SODIUM
004TABLET;ORAL40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1MONOPRILFOSINOPRIL SODIUM

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1991-05-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1991-06-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1991-09-09STANDARD
LABELING; LabelingSUPPL4AP1992-06-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1992-09-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1992-07-10STANDARD
LABELING; LabelingSUPPL7AP1992-10-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1993-04-05STANDARD
EFFICACY; EfficacySUPPL9AP1995-05-02STANDARD
LABELING; LabelingSUPPL10AP1994-05-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1994-06-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1994-12-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1995-03-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-02-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1994-12-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1995-03-27STANDARD
LABELING; LabelingSUPPL17AP1996-07-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1995-09-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1996-03-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1996-08-02STANDARD
LABELING; LabelingSUPPL21AP1997-01-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1997-01-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1997-02-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1997-09-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1997-10-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1998-01-28STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1998-08-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1999-03-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1999-05-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL30AP1999-05-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL31AP1999-11-16STANDARD
LABELING; LabelingSUPPL32AP2002-08-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL33AP2000-06-26STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL34AP2000-09-21STANDARD
EFFICACY; EfficacySUPPL37AP2003-05-27STANDARD
LABELING; LabelingSUPPL38AP2003-10-29STANDARD
LABELING; LabelingSUPPL42AP2009-02-09STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0
SUPPL30Null0
SUPPL31Null0
SUPPL32Null0
SUPPL33Null0
SUPPL34Null0
SUPPL37Null0
SUPPL38Null0
SUPPL42Null0

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19915
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"MONOPRIL","activeIngredients":"FOSINOPRIL SODIUM","strength":"10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"MONOPRIL","activeIngredients":"FOSINOPRIL SODIUM","strength":"20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"MONOPRIL","activeIngredients":"FOSINOPRIL SODIUM","strength":"40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"05\/27\/2003","submission":"SUPPL-37","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/19915se5-037_monopril_lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"MONOPRIL","submission":"FOSINOPRIL SODIUM","actionType":"10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"MONOPRIL","submission":"FOSINOPRIL SODIUM","actionType":"20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"MONOPRIL","submission":"FOSINOPRIL SODIUM","actionType":"40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2003-05-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.